Regenerative medicine company Avita Medical has commenced the pivotal study of RECELL system for soft tissue reconstruction. The company has recruited the first patient at the...
PerkinElmer has collaborated with Public Health England’s (PHE) on Severe Combined Immunodeficiency (SCID) evaluation programme. The company has been selected as one of the providers of...
TPG Development-backed Asia Healthcare Holdings (AHH) has held early discussions to accumulate a major stake in maternity and childcare hospital chain Cloudnine, a number of folks within...
AbbVie and Roche notched a big win for blood cancer therapy Venclexta with a late 2018 FDA approval in the ultra-competitive acute myeloid leukemia (AML) market. But...
Bangalore, Tricog, one of the world’s largest healthcare analytics firms, has raised 10.5 million USD in Series B funding round from UTEC – The University of...
As questions about suspected carcinogens in drugs continue to roil the supply chain, the FDA last month said its testing of metformin did not find any...
With the FDA nod for new multiple myeloma med Sarclisa, Sanofi has scored its first approval for a wholly owned oncology medicine in a decade. Sarclisa won approval to...
Clarivate Analytics plc, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has completed its acquisition of Decision Resources Group...
Spaulding Clinical Research today announced that it has been awarded a five-year contract with the U.S. Food and Drug Administration (FDA) Division of Applied Regulatory Science...
DNA Script today announced the presentation of new data in support of the company’s innovative enzymatic DNA synthesis (EDS) technology. The data demonstrate the feasibility of...
Ping An Insurance Company of China, a Chinese conglomerate firm, has launched the Corona Virus Disease 2019 (COVID-19) smart image-reading system. The COVID-19 smart image-reading system...
The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adults with relapsed refractory multiple...
At its early-February annual report, UK’s GlaxoSmithKline outlined its plans to divide the company into two entities. One part will focus on pharmaceuticals and drug development; the other will...
Five years after Martin Shkreli rose to infamy for acquiring the toxoplasmosis treatment Daraprim from Impax Laboratories for $55 million and then jacking the price by 5,000%,...
Two years after Cambridge, Mass.-based Akrevia Therapeutics launched, the company has rebranded itself as Xilio Therapeutics and secured $100.5 million in a Series B financing round that...
Copyright © 2024 Medical Buyer